BAY38-9456 - Pivotal Trial for Diabetes Patient

PHASE3CompletedINTERVENTIONAL
Enrollment

790

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

November 30, 2004

Conditions
Erectile DysfunctionDiabetes Mellitus
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

BAY 38-9456 10 mg tablet prior to intercourse on demand

DRUG

Levitra (Vardenafil, BAY38-9456)

BAY 38-9456 20 mg tablet prior to intercourse on demand

DRUG

Placebo

Placebo tablet prior to intercourse on demand

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY